Literature DB >> 12413960

Identification of the novel splicing variants for the hPXR in human livers.

Shuichi Fukuen1, Tsuyoshi Fukuda, Hideyasu Matsuda, Akihiko Sumida, Isamu Yamamoto, Tadanobu Inaba, Junichi Azuma.   

Abstract

The human pregnane X receptor (hPXR) plays a key role in the regulation of both drug metabolism and efflux by inducing the expression of CYP3A4 and MDR1 gene. Using reverse transcription-polymerase chain reaction (RT-PCR) analysis, we identified seven novel splicing variants of hPXR in tissue from a single human liver. The expression of hPXR-related transcripts in the liver samples of 15 Caucasian individuals was subsequently determined by RT-PCR assays. The pattern of expression levels of these transcripts varied among liver samples. These results suggest that the hPXR is expressed as several different transcripts in liver tissues, apparently due to alternative as well as defective gene splicing. Furthermore, because this study provides the possibility of interindividual differences in hPXR transcript profiles, these alternative splicings for hPXR may largely contribute to the interindividual variability in CYP3A4 and P-glycoprotein induction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413960     DOI: 10.1016/s0006-291x(02)02469-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 2.  Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism.

Authors:  Tomas Smutny; Lucie Hyrsova; Albert Braeuning; Magnus Ingelman-Sundberg; Petr Pavek
Journal:  Arch Toxicol       Date:  2020-11-09       Impact factor: 5.153

3.  5' diversity of human hepatic PXR (NR1I2) transcripts and identification of the major transcription initiation site.

Authors:  Kouichi Kurose; Satoru Koyano; Shinobu Ikeda; Masahiro Tohkin; Ryuichi Hasegawa; Jun-Ichi Sawada
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

4.  Screening for polymorphisms in the PXR gene in a Dutch population.

Authors:  Tessa M Bosch; Maarten Deenen; Roelof Pruntel; Paul H M Smits; Jan H M Schellens; Jos H Beijnen; Irma Meijerman
Journal:  Eur J Clin Pharmacol       Date:  2006-03-28       Impact factor: 2.953

5.  Comparative genomics of xenobiotic metabolism: a porcine-human PXR gene comparison.

Authors:  Callie B Pollock; Margarita B Rogatcheva; Lawrence B Schook
Journal:  Mamm Genome       Date:  2007-04-15       Impact factor: 2.957

6.  Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.

Authors:  L Oleson; L L von Moltke; D J Greenblatt; M H Court
Journal:  Xenobiotica       Date:  2010-02       Impact factor: 1.908

7.  A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response.

Authors:  Nico Scheer; Jillian Ross; Anja Rode; Branko Zevnik; Sandra Niehaves; Nicole Faust; C Roland Wolf
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 8.  PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics.

Authors:  Bin Zhang; Wen Xie; Matthew D Krasowski
Journal:  Pharmacogenomics       Date:  2008-11       Impact factor: 2.533

Review 9.  Role of pregnane X receptor in chemotherapeutic treatment.

Authors:  Wei Zhuo; Lei Hu; Jinfeng Lv; Hongbing Wang; Honghao Zhou; Lan Fan
Journal:  Cancer Chemother Pharmacol       Date:  2014-06-03       Impact factor: 3.333

10.  Characterization of six base pair deletion in the putative HNF1-binding site of human PXR promoter.

Authors:  Yasuhiro Uno; Yoshiko Sakamoto; Kenichi Yoshida; Takashi Hasegawa; Yoshinori Hasegawa; Takeshi Koshino; Ituro Inoue
Journal:  J Hum Genet       Date:  2003-10-29       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.